Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Colgate “Superior” Anti-Cavity Toothpaste Launching In Emerging Markets

This article was originally published in The Tan Sheet

Executive Summary

Colgate-Palmolive CEO Ian Cook highlights innovations targeted to emerging markets, including a new toothpaste containing acid-neutralizing technology for advanced cavity prevention.

You may also be interested in...



Colgate Pushes Acid-Neutralizing Toothpaste As Emerging Market Driver

The firm looks for the launch of the “breakthrough” Colgate Superior Anti-Cavity with Neutrasucar to strengthen its foothold in Brazil, where it commands 71% of the toothpaste market. Colgate says the product is ideal for emerging markets, where tooth decay is a major public health problem.

Colgate Pushes Acid-Neutralizing Toothpaste As Emerging Market Driver

The firm looks for the launch of the “breakthrough” Colgate Superior Anti-Cavity with Neutrasucar to strengthen its foothold in Brazil, where it commands 71% of the toothpaste market. Colgate says the product is ideal for emerging markets, where tooth decay is a major public health problem.

Colgate Pushes Acid-Neutralizing Toothpaste As Emerging-Market Driver

The firm looks for the launch of “breakthrough” Colgate Superior Anti-Cavity with Neutrasucar to strengthen its foothold in Brazil, where it commands 71% of the toothpaste market. Colgate says the product is ideal for emerging markets, where tooth decay is a major public health problem.

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

PS106599

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel